Page 8 - Evofem Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

--Evofem Biosciences, Inc., today presented data at the Academy of Managed Care Pharmacy annual meeting showing EVO100 provided a significant decrease in gonorrhea and chlamydia infections in women as well as additional patient health outcomes related to satisfaction with use of the investigational product. "Findings from these analyses demonstrate the...

Equities analysts expect that Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Rating) will report sales of $4.40 million for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Evofem Biosciences’ earnings, with the highest sales estimate coming in at $5.30 million and the lowest estimate coming in at $3.51 million. Evofem Biosciences posted […]

/PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and...

/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) announced today that the U.S. Food and Drug Administration (FDA) has awarded "Qualified Infectious...

SAN DIEGO, Feb. 9, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., announced today that the U.S. Food and Drug Administration has awarded Qualified Infectious Disease Product Designation to... | February 9, 2022